The poster embargo ends overnight our time. The biopsy results have been submitted, according to YF, and will be published in December. Coupled that with yesterday's trial expansion announcement and the radio interview it would be a huge disappointment not to read about a reported and peer reviewed cancer killing evidence next week.
While this is not to be taken as a Ph1 result it could be used as an indicator how well and how fast the OV works depending on the patient's cancer stage.
YF and management have set the "Expectation Bar" very high, let's hope it turns out to be a POLE VAULT for humans level and not a limbo dance for ants one. Let's hope for an opening of the SP-Vault and not leaving us in Limbo.
GLTA
IMU Price at posting:
4.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)